ClinicalTrials.gg
Not yet recruitingNCT07846332DL-FPAUpdated Sep 29, 2026

Deep Learning for Flap Perfusion Detection

An interventional study of AI-assisted remote monitoring of flap perfusion abnormalities after first-stage auricular reconstruction in Congenital Microtia, sponsored by Jing Xu. Not yet recruiting at 1 site in China. Open to participants aged 6 Years to 40 Years. Per ClinicalTrials.gov, last updated 2026-09-29.

Sponsored by Jing Xu · Not applicable, Interventional, and Diagnostic

How we know

Updated Sep 29, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
232
Allocation
Non-randomized
Ages
6 Years to 40 Years
Sex
All
01

Study summary

The aim of this study is to develop a convolutional neural network-based image recognition model to identify flap perfusion abnormalities after first-stage auricular reconstruction in patients with congenital microtia. In addition, the study seeks to evaluate the real-world performance of this model when applied to clinical flap monitoring.

The main questions addressed are:

  • Can an artificial intelligence (AI) image recognition model accurately detect flap perfusion abnormalities from photographs of the reconstructed ear?
  • Compared with conventional clinical monitoring, does AI-based image recognition alter the incidence of flap-related complications?
  • How accurate is AI-based detection of flap abnormalities, and how satisfied are patients and healthcare providers with this monitoring approach?

The study is divided into two phases.

  • In phase I, investigators will collect postoperative photographs of reconstructed ears and relevant clinical data from patients with congenital microtia undergoing first-stage auricular reconstruction. Images will be annotated based on the clinical judgement of experienced healthcare professionals, and these data will be used to train a convolutional neural network image recognition model. The model's ability to identify flap perfusion abnormalities will then be assessed through internal validation.
  • In phase II, the clinical performance of traditional monitoring methods will be compared with AI-based image recognition monitoring.

Patients admitted between July 2027 and December 2027 who meet the inclusion criteria will receive conventional clinical flap monitoring and routine follow-up and will comprise the control group.

Patients admitted between January 2028 and June 2028 who meet the inclusion criteria will receive flap monitoring using the convolutional neural network-based image recognition module in addition to standard clinical management and follow-up and will comprise the study group.

Investigators will compare postoperative complication rates, the accuracy of detecting flap perfusion abnormalities, and satisfaction among patients and healthcare providers between the two groups.

Participants will:

  • Undergo flap monitoring after first-stage auricular reconstruction according to the clinical follow-up schedule;
  • Provide, or cooperate in the acquisition of, reconstructed ear photographs and relevant clinical data as required by the study;
  • Receive routine follow-up and health education;
  • In the study group, undergo flap monitoring assisted by the image recognition module in addition to conventional monitoring.
02

Conditions studied

  • Congenital Microtia

Browse trials for

Keywords

  • Congenital microtia
  • first-stage auricular reconstruction
  • flap perfusion abnormalities
  • convolutional neural network
  • deep learning
  • medical image recognition
03

In context

Congenital Microtia

33 studies on the registry are indexed under Congenital Microtia; 10 are open to participants now.

This study's planned enrollment of 232 is above the median of 34 across 23 interventional studies indexed under Congenital Microtia.

Browse Congenital Microtia studies →

Lead sponsor

Jing Xu is the lead sponsor of 2 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 6-40 years;
  • Typical microtia morphology consistent with the diagnostic criteria in Chinese Plastic Surgery;
  • Patients after first-stage total auricular reconstruction who have not yet undergone second-stage surgery;
  • The participant or family member is able to use a smartphone.

Exclusion criteria

Exclusion Criteria:

  • Abnormal coagulation or other relevant laboratory findings;
  • Absence of normal fascial coverage on the affected ear, or presence of eczema, infection, or other local abnormalities on the affected side;
  • Severe cognitive impairment or psychiatric disorders;
  • Significant dysfunction of major organs;
  • The patient or family member does not consent to participation in the study.
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Non-randomized
Intervention model
Sequential assignment
Masking
Single (Participant)
Enrollment
232 participants (estimated)

Study arms

  • No intervention
    Control group

    Patients with congenital microtia will undergo first-stage auricular reconstruction with standard flap assessment and routine follow-up, without AI-based remote flap image monitoring.

  • Experimental
    Intervention group

    Participants will undergo first-stage auricular reconstruction and receive AI-assisted remote flap monitoring postoperatively, with scheduled image acquisition and flap assessment conducted according to the study protocol.

    Behavioral: AI-assisted remote monitoring of flap perfusion abnormalities after first-stage auricular reconstruction

Interventions

  • BehavioralAI-assisted remote monitoring of flap perfusion abnormalities after first-stage auricular reconstruction

    In addition to routine outpatient follow-up, an AI image recognition-based remote intelligent monitoring system led by specialist nurses will be implemented. After discharge, patients will receive daily prompts to upload photographs of the reconstructed ear. The AI system will analyse images in real time: if classified as normal, it will provide standard care recommendations; if classified as abnormal, it will automatically alert the clinical team. Specialist nurses will manually review abnormal images and, as appropriate, request repeat imaging, intensify home care and increase monitoring frequency, or report to the supervising physician and instruct the patient to return to the hospital for further management.

06

What researchers measure

Primary outcomes

  1. Complication rate

    Complications will be identified and recorded based on outpatient review notes and follow-up records. The complication rate will be calculated as: Complication rate = (number of patients with complications after first-stage auricular reconstruction / total number of patients) × 100%. The following common postoperative complications after first-stage auricular reconstruction will be included: hematoma requiring re-hemostasis, infection, flap necrosis, cartilage exposure, and deformation of the auricular framework.

    Time frame: Assessed 3 months postoperatively

Secondary outcomes

  1. Patient satisfaction

    Patient satisfaction will be assessed using a self-designed satisfaction questionnaire comprising 15 items divided into five domains: consultation process and environment (3 items), quality of medical and nursing services (3 items), attitude of medical and nursing staff (3 items), health education (3 items), and use of the case management platform (3 items). Each item will be rated on a 3-point Likert scale from "dissatisfied" to "satisfied," scored 1-3, yielding a total score range of 15-45. The satisfaction score will be calculated as the sum of all item scores, with higher scores indicating greater patient satisfaction.

    Time frame: Assessed 3 months postoperatively

  2. System complication detection rate

    The system complication detection rate will be calculated as: System complication detection rate = (number of cases classified as abnormal by the system and clinically confirmed to have auricular reconstruction complications / total number of cases classified as abnormal by the system) × 100%.

    Time frame: Assessed at 3 months postoperatively

07

Study locations

1 site
08

References and documents

Publications

  • Chen ZH, Lin L, Wu CF, Li CF, Xu RH, Sun Y. Artificial intelligence for assisting cancer diagnosis and treatment in the era of precision medicine. Cancer Commun (Lond). 2021 Nov;41(11):1100-1115. doi: 10.1002/cac2.12215. Epub 2021 Oct 6. PubMed 34613667 ↗
  • Lu MY, Williamson DFK, Chen TY, Chen RJ, Barbieri M, Mahmood F. Data-efficient and weakly supervised computational pathology on whole-slide images. Nat Biomed Eng. 2021 Jun;5(6):555-570. doi: 10.1038/s41551-020-00682-w. Epub 2021 Mar 1. PubMed 33649564 ↗
  • van der Voort SR, Incekara F, Wijnenga MMJ, Kapsas G, Gahrmann R, Schouten JW, Nandoe Tewarie R, Lycklama GJ, De Witt Hamer PC, Eijgelaar RS, French PJ, Dubbink HJ, Vincent AJPE, Niessen WJ, van den Bent MJ, Smits M, Klein S. Combined molecular subtyping, grading, and segmentation of glioma using multi-task deep learning. Neuro Oncol. 2023 Feb 14;25(2):279-289. doi: 10.1093/neuonc/noac166. PubMed 35788352 ↗
  • Blaicher W, Pokorny H, Rockenschaub S, Puhalla H, Muhlbacher F. Organ transplantation in Austria. Ann Transplant. 1996;1(3):41-4. No abstract available. PubMed 9869919 ↗
  • Chen X, Wang X, Zhang K, Fung KM, Thai TC, Moore K, Mannel RS, Liu H, Zheng B, Qiu Y. Recent advances and clinical applications of deep learning in medical image analysis. Med Image Anal. 2022 Jul;79:102444. doi: 10.1016/j.media.2022.102444. Epub 2022 Apr 4. PubMed 35472844 ↗
  • Li J, Jiang P, An Q, Wang GG, Kong HF. Medical image identification methods: A review. Comput Biol Med. 2024 Feb;169:107777. doi: 10.1016/j.compbiomed.2023.107777. Epub 2023 Dec 5. PubMed 38104516 ↗
  • Jia Z, Wang K, Li Y, Liu Z, Qin J, Yang Q. High Precision Feature Fast Extraction Strategy for Aircraft Attitude Sensor Fault Based on RepVGG and SENet Attention Mechanism. Sensors (Basel). 2022 Dec 9;22(24):9662. doi: 10.3390/s22249662. PubMed 36560031 ↗
  • Koshy R, Mahmood A. Optimizing Deep CNN Architectures for Face Liveness Detection. Entropy (Basel). 2019 Apr 20;21(4):423. doi: 10.3390/e21040423. PubMed 33267137 ↗
  • Zhang J, Xie Y, Wu Q, Xia Y. Medical image classification using synergic deep learning. Med Image Anal. 2019 May;54:10-19. doi: 10.1016/j.media.2019.02.010. Epub 2019 Feb 18. PubMed 30818161 ↗
  • Greener JG, Kandathil SM, Moffat L, Jones DT. A guide to machine learning for biologists. Nat Rev Mol Cell Biol. 2022 Jan;23(1):40-55. doi: 10.1038/s41580-021-00407-0. Epub 2021 Sep 13. PubMed 34518686 ↗
  • Fu YY, Li CL, Zhang JL, Zhang TY. Autologous cartilage microtia reconstruction: Complications and risk factors. Int J Pediatr Otorhinolaryngol. 2019 Jan;116:1-6. doi: 10.1016/j.ijporl.2018.09.035. Epub 2018 Oct 2. PubMed 30554677 ↗
  • Reinisch JF, van Hovell Tot Westerflier CVA, Gould DJ, Tahiri YT. Secondary Salvage of the Unsatisfactory Microtia Reconstruction. Plast Reconstr Surg. 2020 May;145(5):1252-1261. doi: 10.1097/PRS.0000000000006766. PubMed 32332549 ↗
  • Li Q, Zhou X, Wang Y, Qian J, Zhang Q. Auricular reconstruction of congenital microtia by using the modified Nagata method: Personal 10-Year experience with 1350 cases. J Plast Reconstr Aesthet Surg. 2018 Oct;71(10):1462-1468. doi: 10.1016/j.bjps.2018.05.036. Epub 2018 Jun 19. PubMed 30097399 ↗
  • Fan Y, Liu W, Fan X, Niu X, Chen X. Psychosocial status of patients with unilateral and bilateral microtia before auricular reconstruction surgery. Int J Pediatr Otorhinolaryngol. 2021 Dec;151:110928. doi: 10.1016/j.ijporl.2021.110928. Epub 2021 Sep 25. PubMed 34607045 ↗
  • Chen X, Ma J, Zhang T. Genetics and Epigenetics in the Genesis and Development of Microtia. J Craniofac Surg. 2024 Feb 12;35(3):e261-6. doi: 10.1097/SCS.0000000000010004. Online ahead of print. PubMed 38345940 ↗
  • Deng K, Dai L, Yi L, Deng C, Li X, Zhu J. Epidemiologic characteristics and time trend in the prevalence of anotia and microtia in China. Birth Defects Res A Clin Mol Teratol. 2016 Feb;106(2):88-94. doi: 10.1002/bdra.23462. Epub 2015 Dec 17. PubMed 26681129 ↗

Individual participant data

Plan to share: No — Individual participant data will not be shared with external researchers due to patient privacy protection and institutional data policy. Aggregated study results will be reported in publications.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Sep 2026; primary completion for Dec 2027, 15 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 23, 2026
First posted
Sep 29, 2026
StartEst.
Sep 22, 2026
Primary completionEst.
Dec 31, 2027
CompletionEst.
Dec 31, 2028
Last update
Sep 29, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Sep 29, 2026
Show all 1 update
  1. Sep 29, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07846332
Lead sponsor
Jing Xu
Responsible party
Jing Xu (Charge Nurse Practitioner, Eye & ENT Hospital of Fudan University) — Sponsor-investigator
First posted
Sep 29, 2026
Start date
Sep 22, 2026 (estimated)
Primary completion
Dec 31, 2027 (estimated)
Completion
Dec 31, 2028 (estimated)
Last update
Sep 29, 2026

Study contacts

Jiaying Gao
Contact
1254091997@qq.com
+86 13795315458

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion